~333 spots leftby Jan 2027

Fitbit Data for Detecting Infections After Appendicitis Surgery

(i-DETECT Trial)

Recruiting in Palo Alto (17 mi)
+3 other locations
FA
HG
Arun Jayaraman, PT, PhD
Overseen byArun Jayaraman, PT, PhD
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Disqualifiers: Non-ambulatory, Mobility limitations, Language barriers, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to analyze Fitbit data to predict infection after surgery for complicated appendicitis and the effect this prediction has on clinician decision making.

Do I need to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Infection-Prediction Algorithm for detecting infections after appendicitis surgery?

The study on machine learning for predicting postoperative sepsis after appendectomy suggests that algorithms can help identify factors associated with infections, indicating potential for similar methods to predict infections after appendicitis surgery.12345

Is it safe to use Fitbit data for detecting infections after appendicitis surgery?

Research shows that using Fitbit devices to monitor recovery after appendicitis surgery in children is safe. These devices help track physical activity and detect complications early without any reported safety concerns.678910

How does the Infection-Prediction Algorithm treatment differ from other treatments for detecting infections after appendicitis surgery?

The Infection-Prediction Algorithm uses data from a Fitbit wearable device to monitor physical activity, heart rate, and sleep, allowing for early detection of abnormal recovery patterns after appendicitis surgery. This approach is unique because it provides objective, real-time monitoring at home, unlike traditional methods that rely on subjective assessments by caregivers.26789

Research Team

Arun Jayaraman, PT, PhD

Arun Jayaraman, PT, PhD

Principal Investigator

Shirley Ryan AbilityLab

FA

Fizan Abdullah, MD, PhD

Principal Investigator

Ann & Robert H Lurie Children's Hospital of Chicago

HG

Hassan Ghomrawi, PhD, MPH

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

This trial is for pediatric patients who have undergone surgery for complicated appendicitis. Specific eligibility criteria are not provided, but typically participants would be children with recent appendectomies.

Inclusion Criteria

I had surgery to remove my appendix due to severe infection or rupture.
I am between 3 and 18 years old.

Exclusion Criteria

My child has a health condition that affects their recovery.
My child cannot walk or has difficulty moving around.
My child has been advised to limit physical activity for more than 48 hours after surgery.
See 1 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Postoperative Monitoring

Participants' Fitbit data (PA, HR, Sleep) is collected and analyzed using ML methods to predict infection during the recovery period.

4 weeks
Continuous data collection

Follow-up

Participants are monitored for safety and effectiveness after treatment, including daily diary/survey submissions for symptoms and healthcare utilization.

4 weeks
Daily virtual submissions

Implementation of Algorithm

Clinicians receive daily reports and near real-time alerts based on Fitbit data to assess the impact on clinical decision-making and healthcare utilization.

4 weeks

Treatment Details

Interventions

  • Infection-Prediction Algorithm (Behavioural Intervention)
Trial OverviewThe study is testing an infection-prediction algorithm using data from Fitbits to foresee infections after appendectomy in young patients and how these predictions influence doctors' decisions.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Aim 2 - Implementation of AlgorithmExperimental Treatment1 Intervention
2a. Exploratory \& Inductive analysis * one transcript will be coded to generate initial themes, using qualitative analytic software 2b. Time to first contact with the healthcare system \& Healthcare use * Cox regression model will be used to model the time to first contact, adjusted for covariates * All comparisons between the two groups will be tested using a chi-square test. Cost will be modeled as a continuous variable and is expected to be skewed, as is typical of cost data. We will use a general linear model (GLM) to model cost outcomes.
Group II: Aim 1 - ValidationActive Control1 Intervention
1a. Development and Internal validation * analyze Fitbit data (PA, HR, sleep) by applying ML methods to create an infection algorithm indicating onset of infection. 1b. External Validation * Once the ML classifier has been internally validated (using Lurie Children's data only) for its ability to detect the presence or absence of postoperative infection using LOSO cross-validation, where each subject is iteratively held out from the training data and used as a test set. External validation will involve applying this classifier to a newer cohort at LCH and cohorts at Loyola University Hospital and CDH and evaluating its performance.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ann & Robert H Lurie Children's Hospital of Chicago

Lead Sponsor

Trials
275
Recruited
5,182,000+

Dr. Michael D. Kelleher

Ann & Robert H Lurie Children's Hospital of Chicago

Chief Medical Officer since 2012

MD from University of Chicago

Dr. Thomas Shanley profile image

Dr. Thomas Shanley

Ann & Robert H Lurie Children's Hospital of Chicago

Chief Executive Officer since 2019

MD from University of Chicago Pritzker School of Medicine

Loyola University Chicago

Collaborator

Trials
23
Recruited
13,100+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+
Dr. Jeffrey Sherman profile image

Dr. Jeffrey Sherman

Northwestern University

Chief Medical Officer

MD from Northwestern University

Dr. Alicia Löffler profile image

Dr. Alicia Löffler

Northwestern University

Chief Executive Officer since 2010

PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech

Central DuPage Hospital

Collaborator

Trials
15
Recruited
3,900+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+
Pete Salzmann profile image

Pete Salzmann

University of Chicago

Chief Executive Officer since 2018

MD from University of Chicago’s Pritzker School of Medicine, MBA from Stanford University’s Graduate School of Business

Anh Nguyen profile image

Anh Nguyen

University of Chicago

Chief Medical Officer

MD from Rutgers New Jersey Medical School, MBA from University of Chicago

Findings from Research

Machine learning algorithms applied to a large dataset of 223,214 appendectomies showed moderate accuracy in predicting postoperative sepsis, with an overall occurrence rate of 0.96%.
Key risk factors identified for postoperative sepsis included preoperative congestive heart failure, transfusion, and acute renal failure, which could help in early intervention and reducing complications.
Application of machine learning to the prediction of postoperative sepsis after appendectomy.Bunn, C., Kulshrestha, S., Boyda, J., et al.[2022]
In a study of 476 patients undergoing appendectomy, a computer-aided diagnosis system was developed to differentiate between acute appendicitis and normal appendixes, but it showed no significant improvement over traditional clinical diagnosis.
The abdominal pain index derived from the analysis had a sensitivity of 82% but a low specificity of 39%, meaning while it could correctly identify many cases of appendicitis, it also misclassified a significant number of patients, potentially leading to unnecessary surgeries.
A feasibility study of computer aided diagnosis in appendicitis.Van Way, CW., Murphy, JR., Dunn, EL., et al.[2009]
Approximately 250,000 cases of appendicitis occur annually in the U.S., with the highest incidence in males aged 10-19 years, indicating a significant public health concern.
The lifetime risk of developing appendicitis is about 8.6% for males and 6.7% for females, with a notable decline in appendicitis rates of 14.6% from 1970 to 1984, although the reasons for this decrease remain unclear.
The epidemiology of appendicitis and appendectomy in the United States.Addiss, DG., Shaffer, N., Fowler, BS., et al.[2022]

References

Application of machine learning to the prediction of postoperative sepsis after appendectomy. [2022]
A feasibility study of computer aided diagnosis in appendicitis. [2009]
The epidemiology of appendicitis and appendectomy in the United States. [2022]
Diagnosis and classification of pediatric acute appendicitis by artificial intelligence methods: An investigator-independent approach. [2020]
Temporal Trends in the Investigation, Management and Outcomes of Acute Appendicitis over 15 Years in the North of England: A Retrospective Cohort Study. [2022]
Using Consumer Wearable Devices to Profile Postoperative Complications After Pediatric Appendectomy. [2023]
Applying machine learning to consumer wearable data for the early detection of complications after pediatric appendectomy. [2023]
Utility of Wearable Sensors to Assess Postoperative Recovery in Pediatric Patients After Appendectomy. [2021]
Using Wearable Devices to Profile Demographic-Specific Recovery After Pediatric Appendectomy. [2023]
Continuous Digital Assessment for Weight Loss Surgery Patients. [2020]